The somatostatin receptor family.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Life Science

• Publication date

  1995-08-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0024-3205(95)02082-TPMID 7674817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P'rinted in Great Britain

  2005cited by this paper
• Genome sequence of the nematode C. elegans: a platform for investigating biology.

  1998cited by this paper
• Characterization of the proximal promoter region of the rat somatostatin receptor gene, SSTR4.

  1995cited by this paper
• Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.

  1995cited by this paper
• A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.

  1995cited by this paper
• Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201‐995 for the SSTR2 somatostatin receptor.

  1995cited by this paper
• Classification and nomenclature of somatostatin receptors.

  1995cited by this paper
• Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary cells.

  1995cited by this paper
• Sequence analysis of the promoter region of the rat somatostatin receptor subtype 1 gene

  1994cited by this paper
• Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.

  1994cited by this paper
• Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors.

  1994cited by this paper
• Sequence analysis of the 5'-flanking promoter region of the human somatostatin receptor 5.

  1994cited by this paper
• Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2 and SSTR3 in adult rat brain: analysis by RNA blotting and in situ hybridization histochemistry.

  1994cited by this paper
• 6agonist selectivity determinants in somatostatin receptor subtypes I and II.

  1994cited by this paper
• Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2.

  1994cited by this paper
• All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase.

  1994cited by this paper
• Transfected human somatostatin receptor type 2, SSTR2, not only inhibits adenylate cyclase but also stimulates phospholipase C and Ca2+ mobilization.

  1994cited by this paper
• Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.

  1994cited by this paper
• The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins.

  1994cited by this paper
• Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat.

  1994cited by this paper
• Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors.

  1994cited by this paper
• Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.

  1994cited by this paper
• Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding.

  1994cited by this paper
• The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells.

  1994cited by this paper
• Molecular pharmacology of somatostatin receptors

  1994cited by this paper
• 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans

  1994cited by this paper
• Somatostatin receptor subtype SSTR2 mediates the inhibition of high‐voltage‐activated calcium channels by somatostatin and its analogue SMS 201‐995

  1994cited by this paper
• Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.

  1994cited by this paper
• Molecular Pharmacology of Somatostatin‐receptor Subtypes

  1994cited by this paper
• Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.

  1994cited by this paper
• Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

  1994cited by this paper
• Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade.

  1994cited by this paper
• Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype.

  1994cited by this paper
• Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).

  1994cited by this paper
• Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs.

  1994cited by this paper
• Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase

  1994cited by this paper
• Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20.

  1993cited by this paper
• Cloning and characterization of a fourth human somatostatin receptor.

  1993cited by this paper
• A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin‐14 like peptides

  1993cited by this paper
• Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2.

  1993cited by this paper
• Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.

  1993cited by this paper
• The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ m coupling efficiency to adenylate cyclase and in agonist‐induced receptor desensitization

  1993cited by this paper
• Identification and quantification of Gi-type GTP-binding proteins that copurify with a pituitary somatostatin receptor.

  1993cited by this paper
• Affinity purification of a somatostatin receptor-G-protein complex demonstrates specificity in receptor-G-protein coupling.

  1993cited by this paper
• Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation.

  1993cited by this paper
• Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.

  1993cited by this paper
• Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat.

  1993cited by this paper
• Human somatostatin receptor genes: localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms.

  1993cited by this paper
• Pharmacological properties of two cloned somatostatin receptors.

  1992cited by this paper
• Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase.

  1992cited by this paper
• Expression cloning of a rat brain somatostatin receptor cDNA.

  1992cited by this paper
• Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.

  1992cited by this paper
• Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28.

  1992cited by this paper
• Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells.

  1992cited by this paper
• Solubilization and partial purification of somatostatin-28 preferring receptors from hamster pancreatic beta cells.

  1992cited by this paper
• Inhibition of the omega-conotoxin-sensitive calcium current by distinct G proteins.

  1992cited by this paper
• Cloning and expression of a rat somatostatin receptor enriched in brain.

  1992cited by this paper
• Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain.

  1992cited by this paper
• Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.

  1992cited by this paper
• Purification of a pituitary receptor for somatostatin. The utility of biotinylated somatostatin analogs.

  1992cited by this paper
• G Protein Activation of a Hormone-Stimulated Phosphatase in Human Tumor Cells

  1992cited by this paper
• Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)

  1992cited by this paper
• Inhibition of the ω-conotoxin-sensitive calcium current by distinct G proteins

  1992cited by this paper
• Photoaffinity labeling of the somatostatin receptor: identification of molecular subtypes.

  1992cited by this paper
• Molecular cloning and functional expression of a brain-specific somatostatin receptor.

  1992cited by this paper
• Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents

  1991cited by this paper
• Somatostatin activates an inwardly rectifying K+ conductance in freshly dispersed rat somatotrophs.

  1991cited by this paper
• Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats.

  1991cited by this paper
• The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

  1991cited by this paper
• Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: effects on cell cycle parameters and apoptotic cell death.

  1991cited by this paper
• Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorylation

  1991cited by this paper
• Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current

  1990cited by this paper
• Evidence That Receptor‐Linked G Protein Inhibits Exocytosis by a Post‐Second‐Messenger Mechanism in AtT‐20 Cells

  1990cited by this paper
• Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins.

  1990cited by this paper
• Identification of somatostatin receptors by covalent labeling with a novel photoreactive somatostatin analog.

  1990cited by this paper
• Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.

  1989cited by this paper
• Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells.

  1989cited by this paper
• Regulation of ATP-sensitive K+ channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP.

  1989cited by this paper
• Beta-adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP.

  1989cited by this paper
• Distinct subsets of somatostatin receptors on cultured human lymphocytes.

  1989cited by this paper
• Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons.

  1989cited by this paper
• Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.

  1989cited by this paper
• Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.

  1989cited by this paper
• Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain.

  1989cited by this paper
• Purification of a putative brain somatostatin receptor.

  1989cited by this paper
• Peptides derived from cleavage of prosomatostatin at carboxyl- and amino-terminal segments. Characterization of tissue and secreted forms in the rat.

  1988cited by this paper
• Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. I. An increase in potassium conductance is responsible for both the hyperpolarization and the decrease in intracellular free calcium produced by somatostatin.

  1988cited by this paper
• Distribution of somatostatin receptors in RINm5F insulinoma cells.

  1988cited by this paper
• Characteristics of somatostatin desensitization in the pituitary tumor cell line AtT-20.

  1988cited by this paper
• Decrease in number of somatostatin receptors in rat brain after adrenalectomy: normalization after glucocorticoid replacement.

  1988cited by this paper
• Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.

  1988cited by this paper
• Somatostatin receptors on rat cerebrocortical membranes. Structural characterization of somatostatin-14 and somatostatin-28 receptors and comparison with pancreatic type receptors.

  1988cited by this paper
• In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue.

  1988cited by this paper
• Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin.

  1988cited by this paper
• Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography.

  1987cited by this paper
• Reconstitution of somatostatin and muscarinic receptor mediated stimulation of K+ channels by isolated GK protein in clonal rat anterior pituitary cell membranes.

  1987cited by this paper
• Somatostatin mediation of adenohypophysial secretion.

  1986cited by this paper
• Quantitative in vivo autoradiographic localization of [125I-Tyr11]somatostatin-14- and [Leu8,D-Trp22-125I-Tyr25]somatostatin-28-binding sites in rat brain.

  1986cited by this paper
• Distribution of somatostatin receptors in the human brain: an autoradiographic study.

  1986cited by this paper
• Two types of somatostatin receptors differentiated by cyclic somatostatin analogs.

  1985cited by this paper

• Effect of Structural Alteration in Albumin Binder Moiety on Tumor Accumulation of Somatostatin Receptor 2‑Targeted Radioligands.

  2026cites this paper
• Somatostatin Analogs for Preventing Postoperative Pancreatic Fistula: Past Evidence Reveals New Opportunities

  2025cites this paper
• A Case of Acromegaly With Parasellar Meningioma With Oculomotor Palsy Responding to and Maintained With Oral Octreotide Therapy

  2025cites this paper
• Impact of pre-reconstruction filtering with butterworth filter on 111In-pentetreotide SPECT image quality and quantitative accuracy: A phantom study.

  2025cites this paper
• Somatostatin Receptors Shape Insulin and Glucagon Output within the Pancreatic Islet through Direct and Paracrine Effects

  2025cites this paper
• Somatostatin receptors in GtoPdb v.2025.3

  2025cites this paper
• Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors

  2024cites this paper
• Expression of somatostatin receptors in canine and feline meningioma

  2024cites this paper
• Exploring the Painless Nature and Potential Mechanisms of Asymptomatic Irreversible Pulpitis: A Narrative Review

  2024cites this paper
• Somatostatin receptors in GtoPdb v.2023.1

  2023cites this paper
• Meningiomas and Somatostatin Analogs: A Systematic Scoping Review on Current Insights and Future Perspectives

  2023cites this paper
• Electrochemical Separation and Purification of No-Carrier-Added 177Lu for Radiopharmaceutical Preparation: Translation from Bench to Bed

  2023cites this paper
• Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe

  2023cites this paper
• Overview of angiogenesis and oxidative stress in cancer

  2023cites this paper
• Cryo-EM structure of the human somatostatin receptor 2 complex with its agonist somatostatin delineates the ligand-binding specificity

  2022cites this paper
• Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity

  2022cites this paper
• The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas

  2022cites this paper
• Genome-wide association study meta-analysis of neurofilament light (NfL) levels in blood reveals novel loci related to neurodegeneration

  2022cites this paper
• Cryo-EM structure of human somatostatin receptor 2 complex with its agonist somatostatin delineates the ligand binding specificity

  2022cites this paper
• Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT

  2021cites this paper
• Inhibition of ASIC-Mediated Currents by Activation of Somatostatin 2 Receptors in Rat Dorsal Root Ganglion Neurons

  2021cites this paper
• The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors.

  2021cites this paper
• In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

  2021cites this paper
• Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R–dependent manner

  2021cites this paper
• Regulatory Peptides in Asthma

  2021cites this paper
• Synthesis, in vitro biological activity, hydrolytic stability and docking of new analogs of BIM-23052 containing halogenated amino acids

  2020cites this paper
• Expression of Somatostatin Receptor Subtypes (SSTR-1–SSTR-5) in Pediatric Hematological and Oncological Disorders

  2020cites this paper
• Localization Mechanisms of Radiopharmaceuticals

  2020cites this paper
• Evaluation of a New 177Lu-Labeled Somatostatin Analog for the Treatment of Tumors Expressing Somatostatin Receptor Subtypes 2 and 5

  2020cites this paper
• Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy

  2020influential citation
• Somatostatin type 2 receptor antibody enhances mechanical hyperalgesia in the dorsal root ganglion neurons after sciatic nerve-pinch injury: Evidence of molecular and behavioral studies.

  2020cites this paper
• Paracrine signaling in islet function and survival

  2020cites this paper
• Small molecule somatostatin receptor subtype 4 (sst4) agonists are novel anti-inflammatory and analgesic drug candidates.

  2020cites this paper
• Effect of Somatostatin Analogs on Prostate Volume Somatostatin Analoglarının Prostat Volümü Üzerine Etkisi

  2019cites this paper
• Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids

  2019cites this paper
• Treatment of Neuroendocrine Tumors (NETs) Using Somatostatin Analogs: Current View, Clinical Achievements and Future Perspectives

  2019cites this paper
• Peptide ligand-mediated targeted drug delivery of nanomedicines.

  2019cites this paper
• Somatostatin receptor PET ligands - the next generation for clinical practice.

  2018cites this paper
• Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy

  2018cites this paper
• Physiology of the Hypothalamus Pituitary Unit

  2018cites this paper
• In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous

  2017cites this paper
• A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination.

  2017cites this paper
• Somatostatin: One of the Rare Multifunctional Inhibitors of Mammalian Species.

  2017influential citation
• Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma

  2017cites this paper
• Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

  2016cites this paper
• Peptide aromatic interactions modulated by fluorinated residues: Synthesis, structure and biological activity of Somatostatin analogs containing 3-(3′,5′difluorophenyl)-alanine

  2016cites this paper
• Physiology of Endogenous Somatostatin Family

  2015cites this paper
• The Sertoli cell as the orchestra conductor of spermatogenesis: spermatogenic cells dance to the tune of testosterone

  2015cites this paper
• 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years.

  2015cites this paper
• Basis of Radiopharmaceutical Localization

  2015cites this paper
• Somatostatin Analogs: Future Perspectives and Preclinical Studies-Pansomatostatins

  2015cites this paper
• Effect of Somatostatin on Voltage-Gated CalciumInflux in Isolated Neonatal Rat Carotid Body Type I Cells

  2015cites this paper
• The Use of Radiolabeled Somatostatin Analogue in Medical Diagnosis

  2015cites this paper
• INVESTIGATION OF NOVEL ANTI-INFLAMMATORY AND ANALGESIC MECHANISMS IN CLINICAL STUDIES AND ANIMAL MODELS

  2015cites this paper
• mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer

  2015cites this paper
• Basis of Radiopharmaceutical Localization

  2014cites this paper
• Nanoparticle Ligand Presentation for Targeting Solid Tumors

  2014cites this paper
• Somatostatin receptor-mediated suppression of gabaergic synaptic transmission in cultured rat retinal amacrine cells.

  2014cites this paper
• [DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting.

  2014cites this paper
• Plasma somatostatin-like immunoreactivity increases in the plasma of septic patients and rats with systemic inflammatory reaction: experimental evidence for its sensory origin and protective role.

  2014cites this paper
• Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies

  2014cites this paper
• Emerging drugs for acromegaly

  2014cites this paper
• Advanced Drug Delivery Systems - a Synthetic and Biological Applied Evaluation

  2013cites this paper
• Ligand-Directed AAVP to Deliver a Therapeutic Transgene to Neuroendocrine Tumors of the Pancreas

  2013cites this paper
• Hormones, 2. Peptides and Proteins: Hypothalamic–Pituitary and Calcitropic Hormones

  2013cites this paper
• Influence of membrane ion channel in pituitary somatotrophs by hypothalamic regulators.

  2012cites this paper
• Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide.

  2012cites this paper
• Renal and Hematological Toxicity in Patients of Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE

  2012cites this paper
• Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.

  2012cites this paper
• Efficacy and Tolerability of long-acting Octreotide in the Treatment of Thymic Tumors: Results of a Pilot Trial

  2012cites this paper
• Rôles des peptides dérivés de la préproghréline dans le contrôle de la sécrétion de GH et du comportement alimentaire

  2012cites this paper
• The Effects of Somatostatin on Immune Cells, Functions and Diseases

  2012cites this paper
• [111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study

  2012cites this paper
• Characterization of somatostatin receptor in rat/mice brain : implication in Huntington's disease

  2012influential citation
• Nerve-Driven Immunity

  2012cites this paper
• Gastrointestinal Peptides: Gastrin, Cholecystokinin, Somatostatin, and Ghrelin

  2012cites this paper
• Role of somatostatin receptors in epidermal growth factor mediated EGFR signaling in breast cancer and human embryonic kidney 293 cells

  2012cites this paper
• The Concept of Divergent Targeting through the Activation and Inhibition of Receptors as a Novel Chemotherapeutic Strategy: Signaling Responses to Strong DNA-Reactive Combinatorial Mimicries

  2012cites this paper
• Distribution of somatostatin receptor 5 in mouse and bullfrog retinas.

  2012cites this paper
• Functional imaging of neuroendocrine tumors.

  2011cites this paper
• Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival

  2011cites this paper
• Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours.

  2011cites this paper
• Spacer Effects on in vivo Properties of DOTA‐Conjugated Dimeric [Tyr3]Octreotate Peptides Synthesized by a “CuI‐Click” and “Sulfo‐Click” Ligation Method

  2011cites this paper
• Somatostatin Receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer

  2011cites this paper
• The Use of Diagnostic Radiotracers in Thyroid Cancer

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Comparison of the Anti-inflammatory and Anti-nociceptive Effects of Cortistatin-14 and Somatostatin-14 in Distinct In Vitro and In Vivo Model Systems

  2011cites this paper
• Feeding responses to central administration of several somatostatin analogs in chicks.

  2011cites this paper
• Octreotide inhibits capsaicin‐induced activation of C and Aδ afferent fibres in rat hairy skin in vivo

  2011cites this paper
• Local effects of octreotide on glutamate-evoked activation of Adelta and C afferent fibers in rat hairy skin.

  2010cites this paper
• Somatostatin and somatostatin receptors.

  2010cites this paper
• Receptor activation and inhibition in cellular response to chemotherapeutic combinational mimicries: the concept of divergent targeting

  2010cites this paper
• Novel medical therapies for pituitary tumors.

  2010cites this paper
• Therapeutic targets in neuroendocrine tumours

  2010cites this paper
• The somatostatin receptor subtype 5 in neuroendocrine tumours

  2010cites this paper
• Relative expression of mRNA for the somatostatin receptors in the caudate putamen of C57BL/6J and 129P3/J mice: strain and heroin effects.

  2010influential citation
• New medical strategies for midgut carcinoids.

  2010cites this paper
• Somatostatin Receptor Subtype Expression in Human Thyroid Tumours

  2010cites this paper
• Gastrointestinal Hormones and Neurotransmitters

  2010cites this paper